P22 Economic impact of risankizumab induction therapy on UC-related hospitalisations and work productivity: data from the phase 3 induction study
Posters | June 23, 2025 | Volume: No volume available | Issue: No issue available | Pages: A104-A104
10.1136/gutjnl-2025-bsg.159